Viewing Study NCT00973895

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:16 PM

Ignite Modification Date: 2026-01-17 @ 8:47 PM

Study NCT ID: NCT00973895

Status: COMPLETED

Last Update Posted: 2017-07-02

First Post: 2009-09-05

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module